Author

Tomoko Sahara

Observed name: Sahara, Tomoko

Institutions: Mayo Clinic, Mayo Clinic in Florida

Observed institutions: Mayo Clinic, Mayo Clinic in Florida

OpenAlex ID: A5028936330

Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin

2010 · Malcolm A. Leissring, Enrico Malito, et al. · PLoS ONE · 108

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40

2020 · Caitlin N. Suire, Samer O. Abdul-Hay, et al. · Alzheimer s Research & Therapy · 73

Identification of BACE2 as an avid ß-amyloid-degrading protease

2012 · Samer O Abdul-Hay, Tomoko Sahara, et al. · Molecular Neurodegeneration · 67

Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis

2024 · Heather M. Terron, Sagar J. Parikh, et al. · Alzheimer s Research & Therapy · 22

Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme

2009 · Anthony DelleDonne, Naomi Kouri, et al. · Molecular Neurodegeneration · 8

O4‐03‐07: Cathepsin D knockout mice harbor large and highly selective increases in cerebral Aß42 and tau: Implications for Alzheimer's disease pathogenesis

2009 · Malcolm A. Leissring, Lael Reinstatler, et al. · Alzheimer s & Dementia · 3

O1‐05‐06: Functional cDNA screening identifies BACE‐2 as a principal beta‐amyloid degrading protease

2011 · Samer Abdul‐Hay, Malcolm Leissring, et al. · Alzheimer s & Dementia · 2

Works count: 14

Citation count: 283

H-index: 5

I10-index: 4